FDA can't exclude crooked firms from US regulatory process
This article was originally published in Clinica
Executive Summary
An investigation carried out by the Republican staff of the US House committee on energy and commerce has found that crooked medical device firms cannot be excluded from participating in the FDA regulatory process.